CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BSF Enterprise PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BSF Enterprise PLC
Ground Floor, 31 Old Burlington Street
Phone: +44 2032834590p:+44 2032834590 LONDON, W1S 3AS  United Kingdom Ticker: BSFABSFA

Business Summary
BSF Enterprise PLC is a United Kingdom-based biotech company. The Company is focused on developing biotechnological solutions using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes. The Company operates through its wholly owned subsidiary, 3D Bio-Tissues Limited (3DBT), which is a clinical and cellular agriculture company engaged in producing human corneas that could help restore vision to millions of people. 3DBT has three strands of three intellectual property (IP) each with a different sector focus development and revenue timeline. 3DBT’s City-mix is an animal-free cell growth agent for culturing skin, muscle and fat cells which are used for lab-grown meat and leather production. 3DBT’s Lipopeptide Etsyl actively increases collagen production in human skin cells which can be used in cosmetic and skin care products.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/20249/30/2023Yes-Yes-Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations
9999 Non-classified establishments

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Chairman of the Board MinYang
Chief Executive Officer, Executive Director CheConnon 6/16/2022 6/16/2022
Executive Director, Company Secretary Geoffrey R.Baker
Independent Non-Executive Director Kian JingOw

Business Names
Business Name
BSFA
BSFAF

General Information
Number of Employees: 4 (As of 9/30/2023)
Outstanding Shares: 103,336,937 (As of 3/31/2024)
Stock Exchange: LON
Federal Tax Id: 812224826


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024